Manteca Man Sentenced To Over Six Years In Prison For Possession Of Mdma With Intent To Distribute

SACRAMENTO, Calif. — Jason Matecki, 46, of Manteca, was sentenced today by U.S. District Judge Garland E. Burrell, Jr. to six years and three months in prison for possession with the intent to distribute MDMA, U.S. Attorney Phillip A. Talbert announced.

MDMA, more commonly known as “Ecstasy,” is a Schedule 1 Controlled Substance.  According to the plea agreement, in March and April 2015, law enforcement seized two packages of MDMA destined for Matecki’s residence in Manteca, as well as one package of MDMA sent to Matecki’s condominium in Las Vegas. On April 21, 2015, federal agents searched both of Mateki’s residences. At his residence in Manteca, agents found a variety of drugs, including 1.7 kilograms of cocaine, 608 grams of MDMA and lesser amounts of marijuana, bath salts, steroids, methamphetamine, adrenaline, and prescription pills. A search of the Las Vegas residence resulted in the seizure of additional quantities of drugs, including MDMA. Matecki admitted to importing the MDMA from overseas and using the “dark web” to sell MDMA and cocaine. Mateki’s sentence was based, in part, on his possession of both MDMA and cocaine. 

This case was the product of an investigation by Immigration and Customs Enforcement's (ICE) Homeland Security Investigations (HSI), the Southern Nevada Heroin Task Force (SNHTF), and Manteca Police Department. Assistant U.S. Attorney Kevin Khasigian prosecuted the case.

On March 31, 2017, Matecki’s co-defendant Catalin Kifan, 26, was sentenced to over eight years in prison after pleading guilty to possessing MDMA with intent to distribute.

This was an Organized Crime Drug Enforcement Task Force (OCDETF) case. The OCDETF Program was established in 1982 to conduct comprehensive, multi-level attacks on major drug trafficking and money laundering organizations. The principal mission of the OCDETF program is to identify, disrupt, and dismantle the most serious drug trafficking and money laundering organizations and those primarily responsible for the nation’s drug supply.